在老年人中早期发现听力损失
Sol Ferrán1, Raquel Manrique-Huarte1, Janaina P Lima1
1Clínica Universidad de Navarra, 31008 Pamplona, Spain.
Life (Basel, Switzerland)
|April 27, 2024
概括
在老年人中,对与年龄相关的听力损失 (ARHL) 的查至关重要. 老年人查测试的听力障碍清单 (HHIE-S) 和语音空间素质 (SSQ12) 是早期检测的有效,非侵入性工具.
科学领域:
- 听力学 听力学是指听力学.
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 与年龄相关的听力损失 (ARHL) 是一种常见的影响老年人听力系统的沟通障碍.
- 早期检测和干预对于维持生活质量和降低医疗保健成本至关重要.
研究的目的:
- 在55岁以上的成年人中描述与年龄相关的听力损失.
- 为了确定ARHL的非侵入性,廉价和快速查测试.
主要方法:
- 一项观察性研究包括710名55岁以上的参与者,按听力损失状态分类.
- 评估包括语音空间特质 (SSQ12),老年人查测试听力障碍清单 (HHIE-S),4kHz听力测量,以及平衡,认知,依赖和抑郁的测试.
主要成果:
- 在各组之间发现了HHIE-S和SSQ12分数的显著差异,表明受治疗的个体处于更大的障碍.
- 4kHz听力测量显示了与年龄相关的听力损失进展和性别差异.
- 在延迟治疗和认知功能 (DSST) 之间观察到相关性.
结论:
- 对于ARHL查程序,HHIE-S,SSQ12和4kHz听力测量是敏感和实用的.
- 这些测试可以帮助早期发现和管理老年人听力损失.
更多相关视频
14:05Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses
Published on: January 23, 2017
29.1K
09:15Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages
Published on: April 11, 2025
464
相关概念视频
Hearing
48.0K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
48.0K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
Cognitive Development During Adulthood
1.4K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
